A Region to the N-terminal Side of the CTCF Zinc Finger Domain Is Essential for Activating Transcription from the Amyloid Precursor Protein Promoter*

Transcription from the amyloid precursor protein (APP) promoter is largely dependent on a nuclear factor binding site designated as APBβ. The protein that binds to this site is the multifunctional transcription factor CTCF, which consists of 727 amino acids and contains a domain of 11 zinc finger motifs that is flanked by 267 amino acids on the N-terminal side and 150 amino acids on the C-terminal side. Depleting HeLa cell nuclear extract of endogenous CTCF specifically reduced transcriptional activity from the APPpromoter. However, transcriptional activity was restored by replenishing the depleted extract with recombinant CTCF. Deleting 201 amino acids from the C-terminal end of CTCF had no detrimental effect on transcriptional activation, whereas deleting either 248 or 284 amino acids from the N-terminal end abolished transcriptional activation. Competing endogenous CTCF in vivo was accomplished by cotransfecting COS-1 cells with a plasmid overexpressing CTCF constructs and a reporter plasmid containing the APPpromoter. Under these conditions, an N-terminal deletion of CTCF reduced expression from the APP promoter, whereas the C-terminal deletion had no effect. These results demonstrate that CTCF activates transcription from the APP promoter and that the activation domain is located on the N-terminal side of the zinc finger domain.

[1]  D. Mann,et al.  The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease , 2004, Acta Neuropathologica.

[2]  R Ohlsson,et al.  CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. , 2001, Trends in genetics : TIG.

[3]  P. Neiman,et al.  Functional Phosphorylation Sites in the C-Terminal Region of the Multivalent Multifunctional Transcriptional Factor CTCF , 2001, Molecular and Cellular Biology.

[4]  A. Vostrov,et al.  Differential effect of zinc finger deletions on the binding of CTCF to the promoter of the amyloid precursor protein gene. , 2000, Nucleic acids research.

[5]  G. Brewer,et al.  CTCF Is Essential for Up‐Regulating Expression from the Amyloid Precursor Protein Promoter During Differentiation of Primary Hippocampal Neurons , 1999, Journal of neurochemistry.

[6]  P. Neiman,et al.  Negative Transcriptional Regulation Mediated by Thyroid Hormone Response Element 144 Requires Binding of the Multivalent Factor CTCF to a Novel Target DNA Sequence* , 1999, The Journal of Biological Chemistry.

[7]  A. West,et al.  The Protein CTCF Is Required for the Enhancer Blocking Activity of Vertebrate Insulators , 1999, Cell.

[8]  A. Bigas,et al.  Differential expression and phosphorylation of CTCF, a c‐myc transcriptional regulator, during differentiation of human myeloid cells , 1999, FEBS letters.

[9]  A. Vostrov,et al.  The zinc finger protein CTCF binds to the APBbeta domain of the amyloid beta-protein precursor promoter. Evidence for a role in transcriptional activation. , 1997, The Journal of biological chemistry.

[10]  S. Little,et al.  APP gene promoter constructs are preferentially expressed in the CNS and testis of transgenic mice. , 1997, Biochemical and biophysical research communications.

[11]  Victor V Lobanenkov,et al.  Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF , 1997, Molecular and cellular biology.

[12]  Victor V Lobanenkov,et al.  Molecular weight abnormalities of the CTCF transcription factor: CTCF migrates aberrantly in SDS-PAGE and the size of the expressed protein is affected by the UTRs and sequences within the coding region of the CTCF gene. , 1997, Nucleic acids research.

[13]  R. Kraus,et al.  The Initiator Element and Proximal Upstream Sequences Affect Transcriptional Activity and Start Site Selection in the Amyloid β-Protein Precursor Promoter* , 1996, The Journal of Biological Chemistry.

[14]  P. Neiman,et al.  An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes , 1996, Molecular and cellular biology.

[15]  R. Eisenman,et al.  Novel location and function of a thyroid hormone response element. , 1995, The EMBO journal.

[16]  D. Goldgaber,et al.  USF binds to the APBα sequence in the promoter of the amyloid β-protein precursor gene , 1995 .

[17]  W. Quitschke.  Two nuclear factor binding domains activate expression from the human amyloid beta-protein precursor promoter. , 1994, The Journal of biological chemistry.

[18]  M. Iadarola,et al.  Recombinant proteins attached to a nickel-NTA column: use in affinity purification of antibodies. , 1994, BioTechniques.

[19]  P. Neiman,et al.  CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms , 1993, Molecular and cellular biology.

[20]  R. Renkawitz,et al.  NeP1. A ubiquitous transcription factor synergizes with v-ERBA in transcriptional silencing. , 1993, Journal of molecular biology.

[21]  D. Goldgaber,et al.  The amyloid beta-protein precursor promoter. A region essential for transcriptional activity contains a nuclear factor binding domain. , 1992, The Journal of biological chemistry.

[22]  Colin L. Masters,et al.  The expression of the amyloid precursor protein (APP) is regulated by two GC-elements in the promoter , 1992, Nucleic Acids Res..

[23]  R. Frederickson,et al.  Transcription factor binding and spacing constraints in the human beta-actin proximal promoter. , 1991, Nucleic acids research.

[24]  B. Trapp,et al.  Regulatory region of human amyloid precursor protein (APP) gene promotes neuron‐specific gene expression in the CNS of transgenic mice. , 1991, The EMBO journal.

[25]  K. Beyreuther,et al.  Transplants of mouse trisomy 16 hippocampus provide a model of Alzheimer's disease neuropathology. , 1991, The EMBO journal.

[26]  Victor V Lobanenkov,et al.  A novel sequence-specific DNA binding protein which interacts with three regularly spaced direct repeats of the CCCTC-motif in the 5'-flanking sequence of the chicken c-myc gene. , 1990, Oncogene.

[27]  C. Finch,et al.  Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. , 1990, Science.

[28]  R. Renkawitz,et al.  Modular structure of a chicken lysozyme silencer: Involvement of an unusual thyroid hormone receptor binding site , 1990, Cell.

[29]  S. Younkin,et al.  Expression of β amyloid protein precursor mRNAs: Recognition of a novel alternatively spliced form and quantitation in alzheimer's disease using PCR , 1990, Neuron.

[30]  B. Paterson,et al.  The beta actin promoter. High levels of transcription depend upon a CCAAT binding factor. , 1989, The Journal of biological chemistry.

[31]  R. Neve,et al.  Expression of the Alzheimer amyloid precursor gene transcripts in the human brain , 1988, Neuron.

[32]  R. Tjian,et al.  Temporal pattern of alcohol dehydrogenase gene transcription reproduced by Drosophila stage-specific embryonic extracts , 1988, Nature.

[33]  S. Younkin,et al.  In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Roses,et al.  CELLULAR LOCALIZATION OF MESSENGER RNA ENCODING AMYLOID‐BETA-PROTEIN IN NORMAL TISSUE AND IN ALZHEIMER DISEASE , 1988, Alzheimer disease and associated disorders.

[35]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[36]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Glenner,et al.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. , 1984, Biochemical and biophysical research communications.

[38]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .